14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $36.78 $42.85 Wednesday, 24th Apr 2024 CLDX stock ended at $37.02. This is 1.99% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 2.53% from a day low at $36.96 to a day high of $37.90.
90 days $34.65 $53.18
52 weeks $22.11 $53.18

Historical Celldex Therapeutics prices

Date Open High Low Close Volume
Jun 01, 2023 $31.80 $32.50 $31.28 $32.13 254 659
May 31, 2023 $31.29 $32.61 $30.88 $31.80 357 269
May 30, 2023 $31.14 $31.30 $30.50 $31.18 275 865
May 26, 2023 $30.40 $31.02 $30.28 $30.57 244 761
May 25, 2023 $31.92 $32.36 $30.26 $30.37 328 590
May 24, 2023 $32.41 $32.71 $31.86 $32.01 352 899
May 23, 2023 $33.64 $34.24 $32.72 $32.74 428 299
May 22, 2023 $33.08 $33.77 $33.06 $33.62 258 683
May 19, 2023 $31.78 $32.92 $31.71 $32.89 404 773
May 18, 2023 $31.87 $32.14 $30.66 $31.29 483 476
May 17, 2023 $33.42 $33.61 $32.14 $32.18 336 950
May 16, 2023 $33.52 $33.90 $33.00 $33.25 489 542
May 15, 2023 $34.53 $35.74 $34.07 $34.26 269 911
May 12, 2023 $33.10 $34.40 $32.58 $34.35 299 438
May 11, 2023 $33.27 $33.99 $32.96 $33.07 348 243
May 10, 2023 $33.57 $33.77 $32.88 $33.57 294 827
May 09, 2023 $32.95 $33.28 $32.44 $33.13 350 230
May 08, 2023 $33.37 $33.59 $32.99 $33.36 464 955
May 05, 2023 $31.52 $33.91 $31.52 $33.28 660 566
May 04, 2023 $30.90 $31.92 $30.49 $31.49 514 285
May 03, 2023 $31.06 $32.64 $31.06 $31.46 566 530
May 02, 2023 $31.19 $31.67 $30.44 $30.85 697 837
May 01, 2023 $31.51 $32.31 $31.28 $31.35 502 423
Apr 28, 2023 $31.41 $31.50 $30.60 $31.44 509 590
Apr 27, 2023 $32.29 $33.18 $31.58 $31.73 525 378
Click to get the best stock tips daily for free!

About Celldex Therapeutics

Celldex Therapeutics Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT